Saiz LC, Leache L, Gutierrez-Valencia M, Erviti J, et al. Is chimaeric antigen receptor T-cell therapy really superior to standard of care as second-line therapy for large B-cell lymphoma? Br J Haematol 2022 Oct 25. doi: 10.1111/bjh.18505.
PMID: 36281751